Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nothing Artificial is a private Canadian company based in Montreal that develops cognitive science, artificial intelligence, and blockchain-enabled products intended to enhance human intelligence. Its portfolio includes NeuroTracker, a cognitive training system derived from neuroscience research, and Nile AI, a neurological care platform designed to connect patients with care teams and help optimize treatment decisions. The company appears to operate at the intersection of performance training, brain health, and digital health software rather than as a traditional therapeutics developer. While it has healthcare relevance through neurological care applications, it does not appear to have a conventional biopharma drug pipeline or disclosed therapeutic assets in clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nothing Artificial.